Refine Search
(3)
(5)
(10)
(11)

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape.

The report provides comprehensive info...

Hyperoxaluria - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperoxaluria - Pipeline Review, H2 2016’, provides an overview of the Hyperoxaluria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperoxaluria, com...

Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016’, provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) pipeline landscape.

The report provides comprehensive information on t...

Nephrotic Syndrome - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nephrotic Syndrome - Pipeline Review, H1 2018’, provides an overview of the Nephrotic Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nephroti...

Glomerulonephritis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glomerulonephritis - Pipeline Review, H2 2018’, provides an overview of the Glomerulonephritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Glomerul...

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018’, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape.

The report provides comprehensive inform...

Overactive Bladder - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H2 2018’, provides an overview of the Overactive Bladder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Overacti...

Kidney Fibrosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H2 2018’, provides an overview of the Kidney Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Kidney Fibrosi...

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018’, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline landscape.

The report provi...

Nocturia - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nocturia - Pipeline Review, H1 2019’, provides an overview of the Nocturia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nocturia, complete with anal...

Primary Hyperoxaluria - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Hyperoxaluria - Pipeline Review, H1 2019’, provides an overview of the Primary Hyperoxaluria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pr...

Contrast Induced Nephropathy - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Contrast Induced Nephropathy - Pipeline Review, H1 2019’, provides an overview of the Contrast Induced Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Urinary Incontinence - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H1 2019’, provides an overview of the Urinary Incontinence pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Urin...